speb/financial-data huggingface dataset:
Financial ratios for 1062.HK — annual report dated 2023-12-31
Total revenue: -25801194.750320103
Net income: -27900267.989756722
Capital expenditures: 0
Operating cash flow: 6566645.070422536
Depreciation & amortization: 0
Net tangible assets: 146265572.47119078
Owner earnings: -27900267.989756722
Return on net tangible assets (%): -19.075075233614598
Buffett classification: The Gruesome
Stock price: 0.010243277848911653
Shares outstanding: 2902215360
Book value: 146265572.4711908
P/B ratio: 0.20324809049453227
Market cap (USD): 29728198.30985916
Debt to equity: 0
Free cash flow (dilution-adjusted): 6566645.070422536
Buyback yield (%): 0
Retained earnings: -40158794.62227913
Receivables turnover: -0.8950917875015867
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1062.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 128109024.74226804
Buffett classification: The Gruesome
Stock price: 0.010309278350515464
Shares outstanding: 2902215360
Book value: 128109024.74226804
P/B ratio: 0.23354908867329607
Market cap (USD): 29919745.979381442
Debt to equity: 0.01922215633118035
Buyback yield (%): 0
Retained earnings: -59516530.28350516
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1062.HK — annual report dated 2024-12-31
Total revenue: -17018107.474226806
Net income: -19098980.541237112
Capital expenditures: 0
Operating cash flow: 29346013.273195878
Depreciation & amortization: 319573.7113402062
Net tangible assets: 128109024.74226804
Owner earnings: -18779406.829896905
Return on net tangible assets (%): -14.65892576083351
Buffett classification: The Gruesome
Stock price: 0.010309278350515464
Shares outstanding: 2902215360
Book value: 128109024.74226804
P/B ratio: 0.23354908867329607
Market cap (USD): 29919745.979381442
Debt to equity: 0.01922215633118035
Free cash flow (dilution-adjusted): 29346013.273195878
Buyback yield (%): 0
Retained earnings: -59516530.28350516
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1062.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 125152112.22929937
Buffett classification: The Gruesome
Stock price: 0.011464968152866243
Shares outstanding: 2902215360
Market cap (USD): 33273806.67515924
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2134.T — annual report dated 2022-03-31
Total revenue: 3168267.4971316177
Gross profit: 1784387.8052778235
Operating income: -4746131.781675136
Net income: -10214046.877561055
Capital expenditures: 4117972.463530569
Operating cash flow: -4018906.7366005573
Depreciation & amortization: 728610.0639239469
Net tangible assets: 6524815.603999345
Owner earnings: -13603409.277167676
Return on net tangible assets (%): -208.48726006646922
Buffett classification: The Gruesome
Stock price: 0.23766595640059007
Shares outstanding: 551440992
Book value: 7210039.337813473
P/B ratio: 18.17725876678992
Market cap (USD): 131058750.76217014
Debt to equity: 0.3965665987321672
Current ratio: 0.8278482640377197
Quick ratio: 0.5951893127589656
Interest coverage ratio: -37.02122355046986
COGS to revenue (%): 43.67912424468173
Free cash flow (dilution-adjusted): -8148483.85510572
Buyback yield (%): 0
Retained earnings: -58939149.31978364
Inventory turnover: 1.0369815399353959
Receivables turnover: 16.810540505283296
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.305529527200314
FCF margin (%): -257.1905264464862
Rule of 40 score: -257.1905264464862
Financial ratios for 2134.T — annual report dated 2023-03-31
Total revenue: 2863596.0960960966
Gross profit: 1537552.5525525527
Operating income: -3619549.54954955
Net income: -6788445.9459459465
Capital expenditures: 338168.1681681682
Operating cash flow: -4443355.855855856
Depreciation & amortization: 708423.4234234234
Net tangible assets: 4885397.897897898
Owner earnings: -6418190.690690692
Return on net tangible assets (%): -131.374983672309
Buffett classification: The Gruesome
Stock price: 0.0975975975975976
Shares outstanding: 551440992
Book value: 4942815.3153153155
P/B ratio: 10.888393072117598
Market cap (USD): 53819316.03603604
Debt to equity: 0.5985254783310019
Current ratio: 0.9430504106256565
Quick ratio: 0.8411807986254355
Interest coverage ratio: -69.98461315140078
COGS to revenue (%): 46.306671455649905
Free cash flow (dilution-adjusted): -4480563.063063064
Buyback yield (%): 0
Retained earnings: -60780600.60060061
Inventory turnover: 3.687047281077132
Receivables turnover: 35.75468691413573
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.46452023943232
FCF margin (%): -156.46630714336277
Revenue growth (%): -9.61634083332151
Rule of 40 score: -166.08264797668429
Financial ratios for 2134.T — annual report dated 2024-03-31
Total revenue: 1548395.4041204439
Gross profit: 1180295.826730058
Operating income: -2184363.444268357
Net income: -3230302.4300052826
Capital expenditures: 132587.16323296356
Operating cash flow: -3092069.466455362
Depreciation & amortization: 133280.50713153725
Net tangible assets: 711905.705229794
Owner earnings: -3229609.0861067087
Return on net tangible assets (%): -453.6568624722894
Buffett classification: The Gruesome
Stock price: 0.11885895404120445
Shares outstanding: 551440992
Book value: 1012453.777073428
P/B ratio: 64.73747346177429
Market cap (USD): 65543699.52456419
Debt to equity: 4.788894251464202
Current ratio: 0.39359075524322823
Quick ratio: 0.34638309065102385
Interest coverage ratio: -18.83934164815764
COGS to revenue (%): 23.77297016064719
Free cash flow (dilution-adjusted): -3157580.559957739
Buyback yield (%): 0
Retained earnings: -56699815.10829371
Inventory turnover: 1.465084496307393
Receivables turnover: 58.63690922730683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -80.64771721614221
FCF margin (%): -203.9259837348447
Revenue growth (%): -45.928289040785074
Rule of 40 score: -249.85427277562977
Financial ratios for 2134.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 4850595.321473596
Buffett classification: The Gruesome
Stock price: 0.15408320493066255
Shares outstanding: 551440992
Book value: 7642022.692253816
P/B ratio: 11.118495560557516
Market cap (USD): 84967795.37750384
Debt to equity: 0.33534562397812173
Current ratio: 1.1323781357150433
Quick ratio: 1.0905795991469205
Buyback yield (%): 0
Retained earnings: -62297422.60820843
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2134.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 11285824.087688811
Buffett classification: The Gruesome
Stock price: 0.12030477208929287
Shares outstanding: 551440992
Book value: 13632689.48001604
P/B ratio: 4.866316581222058
Market cap (USD): 66340982.86325357
Debt to equity: 0.12570285278932483
Current ratio: 3.1615735119286863
Quick ratio: 1.7804182549722254
Buyback yield (%): 0
Retained earnings: -62888196.76513835
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2134.T — annual report dated 2025-03-31
Total revenue: 4689259.457291806
Gross profit: 1540054.805507285
Operating income: -3870231.2525063492
Net income: -5564683.865793343
Capital expenditures: 1193837.7222296484
Operating cash flow: -10555253.308381232
Depreciation & amortization: 414784.1197700842
Net tangible assets: 11285824.087688811
Owner earnings: -6343737.468252907
Return on net tangible assets (%): -56.20978511594027
Buffett classification: The Gruesome
Stock price: 0.12030477208929287
Shares outstanding: 551440992
Book value: 13632689.48001604
P/B ratio: 4.866316581222058
Market cap (USD): 66340982.86325357
Debt to equity: 0.12570285278932483
Current ratio: 3.1615735119286863
Quick ratio: 1.7804182549722254
Interest coverage ratio: -74.29612522453169
COGS to revenue (%): 67.15782482215826
Free cash flow (dilution-adjusted): -11749091.03061088
Buyback yield (%): 0
Retained earnings: -62888196.76513835
Inventory turnover: 0.7216698217819356
Receivables turnover: 34.891933558782576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.162770471234754
FCF margin (%): -250.55322994211858
Revenue growth (%): 202.84638179712954
Rule of 40 score: -47.70684814498904
Financial ratios for 2134.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 35004993.2705249
Buffett classification: The Gruesome
Stock price: 0.2960969044414536
Shares outstanding: 551440992
Book value: 40014569.313593544
P/B ratio: 4.080513010991118
Market cap (USD): 163279970.71332437
Debt to equity: 0.17991949432953844
Current ratio: 4.673643354082753
Quick ratio: 2.8516660563896004
Buyback yield (%): 0
Retained earnings: -67329502.01884253
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2576.HK — annual report dated 2024-12-31
Total revenue: 75500821.91780822
Gross profit: 30814109.589041095
Operating income: -34842739.7260274
Net income: -29398493.15068493
Capital expenditures: 732328.7671232877
Operating cash flow: -27618493.15068493
Depreciation & amortization: 5472054.794520548
Net tangible assets: 150634109.5890411
Owner earnings: -24658767.12328767
Return on net tangible assets (%): -16.369975691801507
Buffett classification: The Gruesome
Stock price: 0.5515463917525774
Shares outstanding: 197483133
Book value: 169119589.0410959
P/B ratio: 0.6440478601900849
Market cap (USD): 108921109.43814434
Debt to equity: 0.028153863724542816
Current ratio: 5.048326680155302
Quick ratio: 5.048326680155302
Interest coverage ratio: -349.8651994497937
COGS to revenue (%): 59.18705411897901
R&D to revenue (%): 15.794802197562941
SG&A to revenue (%): 74.20512522770323
Free cash flow (dilution-adjusted): -46125479.4520548
Buyback yield (%): 0
Retained earnings: -233298219.1780822
Receivables turnover: 3.279616792121627
Capitalized R&D asset: 39025079.27910287
ROCI (R&D-adjusted, %): -21.357482452237257
Rosenberg metric: 0.23692938263904226
FCF margin (%): -61.09268519257706
Revenue growth (%): -6.338127910845673
Rule of 40 score: -67.43081310342274
Financial ratios for 2576.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 151973361.22733614
Buffett classification: The Gruesome
Stock price: 0.43312101910828027
Shares outstanding: 197483133
Book value: 169653556.48535565
P/B ratio: 0.5041691880419806
Market cap (USD): 85534095.82165605
Debt to equity: 0.015432220556125536
Current ratio: 5.657003754852671
Quick ratio: 5.657003754852671
Buyback yield (%): 0
Retained earnings: -240708368.20083684
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3071.T — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.9207877841402047
Shares outstanding: 27636500
Market cap (USD): 25447351.596390765
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3071.T — annual report dated 2023-01-31
Total revenue: 231549885.03985286
Gross profit: 42358338.44267321
Operating income: 2935139.484978541
Net income: 1672179.6443899448
Capital expenditures: 197148.9883507051
Operating cash flow: 1128969.9570815451
Depreciation & amortization: 1255954.9356223177
Net tangible assets: 20078839.668914776
Owner earnings: 2730985.5916615576
Return on net tangible assets (%): 13.601311812303358
Capex to operating income (%): 6.716852448058239
Buffett classification: The Great
Stock price: 0.7992029429797671
P/E ratio: 13.208612009936477
Shares outstanding: 27636500
Book value: 22980088.902513795
P/B ratio: 0.9611438940623165
Market cap (USD): 22087172.133660335
Debt to equity: 0.21798453997109168
Current ratio: 1.7530837754171429
Quick ratio: 0.8850743728404259
Effective tax rate (%): 38.68375345084196
Interest coverage ratio: 35.434585492227974
COGS to revenue (%): 81.70660355310358
Free cash flow (dilution-adjusted): -45999.386879215206
Buyback yield (%): 0
Retained earnings: 10009334.763948498
Inventory turnover: 9.132655152614708
Receivables turnover: 20.325795973945418
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.796615369356346
FCF margin (%): -0.019865864701810624
Rule of 40 score: -0.019865864701810624
Financial ratios for 3071.T — annual report dated 2024-01-31
Total revenue: 186272484.2233833
Gross profit: 32596010.042749543
Operating income: 1238861.3693424712
Net income: 206025.64972518152
Capital expenditures: 641487.4126348646
Operating cash flow: -3923546.176290968
Depreciation & amortization: 1161633.9824930446
Net tangible assets: 17734504.98744656
Owner earnings: 726172.2195833615
Return on net tangible assets (%): 4.094685586642454
Capex to operating income (%): 51.78040324038319
Buffett classification: The Good
Stock price: 0.7196172898147519
P/E ratio: 96.53022939859034
Shares outstanding: 27636500
Book value: 20282642.328832187
P/B ratio: 0.9805282224838437
Market cap (USD): 19887703.229965393
Debt to equity: 0.39533792140855323
Current ratio: 1.695662837566823
Quick ratio: 0.7534800533926
Effective tax rate (%): 70.76485351777102
Interest coverage ratio: 20.067157617058694
COGS to revenue (%): 82.50089541442898
Free cash flow (dilution-adjusted): -5463975.028838976
Buyback yield (%): 0
Retained earnings: 8512689.14975911
Inventory turnover: 7.902715228968771
Receivables turnover: 18.1000538037114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.774456779580606
FCF margin (%): -2.9333237550460867
Revenue growth (%): -19.554058862381513
Rule of 40 score: -22.4873826174276
Financial ratios for 3071.T — annual report dated 2025-01-31
Total revenue: 196605924.72420508
Gross profit: 32483231.667748217
Operating income: 1691537.9623621027
Net income: 27034.39325113563
Capital expenditures: 76645.03569110968
Operating cash flow: 6120382.868267359
Depreciation & amortization: 1196093.4458144063
Net tangible assets: 16433932.511356262
Owner earnings: 1146482.8033744323
Return on net tangible assets (%): 6.976314418853696
Capex to operating income (%): 4.531085757252576
Buffett classification: The Great
Stock price: 0.6501622323166775
P/E ratio: 664.6425672107536
Shares outstanding: 27636500
Book value: 18904620.376378976
P/B ratio: 0.9504665090165392
Market cap (USD): 17968208.53341986
Debt to equity: 0.28940457956571497
Current ratio: 1.6487196818644498
Quick ratio: 0.8434883632088608
Effective tax rate (%): 104.40575374393406
Interest coverage ratio: 22.15040788579198
COGS to revenue (%): 83.47799960081821
Free cash flow (dilution-adjusted): 5071466.580142764
Buyback yield (%): 0
Retained earnings: 7629928.617780662
Inventory turnover: 9.676401360518192
Receivables turnover: 17.823709431566886
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.520295461067926
FCF margin (%): 2.579508520537679
Revenue growth (%): 5.547486277377184
Rule of 40 score: 8.126994797914863
Financial ratios for 3071.T — quarterly report dated 2025-04-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.704075895994378
Shares outstanding: 27636500
Market cap (USD): 19458193.499648627
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3071.T — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 16365596.729880052
Buffett classification: The Gruesome
Stock price: 0.7300810828921799
Shares outstanding: 27636500
Book value: 18905736.112041812
P/B ratio: 1.0672361937019883
Market cap (USD): 20176885.84734973
Debt to equity: 0.02899156878931473
Current ratio: 1.6204816072179369
Quick ratio: 0.8488147089966713
Buyback yield (%): 0
Retained earnings: 7277370.5019098045
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3071.T — quarterly report dated 2026-01-31
Capital expenditures: 0
Net tangible assets: 16948047.793157484
Buffett classification: The Gruesome
Stock price: 0.6986158265865762
Shares outstanding: 27636500
Book value: 19465872.290415257
P/B ratio: 0.9918536402279067
Market cap (USD): 19307296.29145991
Debt to equity: 0.22583067713649285
Current ratio: 1.616378233968792
Quick ratio: 0.9021460508785514
Buyback yield (%): 0
Retained earnings: 8119574.301384173
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3071.T — annual report dated 2026-01-31
Total revenue: 213991316.27056673
Gross profit: 34125483.154870726
Operating income: 1839814.5729955602
Net income: 984134.2387046226
Capital expenditures: 20827.892400104465
Operating cash flow: 5970867.0671193525
Depreciation & amortization: 1125039.174719248
Net tangible assets: 16948047.793157484
Owner earnings: 2088345.5210237661
Return on net tangible assets (%): 12.322041727230104
Capex to operating income (%): 1.132064758362729
Buffett classification: The Great
Stock price: 0.6986158265865762
P/E ratio: 19.61855967624229
Shares outstanding: 27636500
Book value: 19465872.290415257
P/B ratio: 0.9918536402279067
Market cap (USD): 19307296.29145991
Debt to equity: 0.22583067713649285
Current ratio: 1.616378233968792
Quick ratio: 0.9021460508785514
Effective tax rate (%): 35.184361536985676
Interest coverage ratio: 42.13937490653507
COGS to revenue (%): 84.0528623877228
Free cash flow (dilution-adjusted): 4947127.187255158
Buyback yield (%): 0
Retained earnings: 8119574.301384173
Inventory turnover: 10.761766620074958
Receivables turnover: 18.6053631277305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.969109146240346
FCF margin (%): 2.3118354863522126
Revenue growth (%): 8.842760751360643
Rule of 40 score: 11.154596237712855
Financial ratios for 3160.T — annual report dated 2022-05-31
Total revenue: 435847652.2147441
Gross profit: 85189231.49162623
Operating income: 1079762.091094068
Net income: 135302.8642980122
Capital expenditures: 2810431.9924870874
Operating cash flow: 2445429.644701831
Depreciation & amortization: 3688785.41242761
Net tangible assets: 33060111.128502112
Owner earnings: 1013656.2842385345
Return on net tangible assets (%): 3.0661006561609256
Capex to operating income (%): 260.2825210912359
Buffett classification: The Gruesome
Stock price: 5.1582407262482395
P/E ratio: 544.2758217687548
Shares outstanding: 14276588
Book value: 33241579.276882127
P/B ratio: 2.2153603786412552
Market cap (USD): 73642077.6534669
Debt to equity: 1.1770490174589994
Current ratio: 1.0691669889753102
Quick ratio: 0.6398944869019811
Effective tax rate (%): 80.94351060898319
Interest coverage ratio: 6.678218780251695
COGS to revenue (%): 80.45435576887009
Free cash flow (dilution-adjusted): -414110.18938801065
Buyback yield (%): 0
Retained earnings: 16961355.454687744
Inventory turnover: 10.34352893649438
Receivables turnover: 11.111020601806409
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.762815168755452
FCF margin (%): -0.09501260068368493
Rule of 40 score: -0.09501260068368493
Financial ratios for 3160.T — annual report dated 2023-05-31
Total revenue: 463735016.8109307
Gross profit: 88637270.19100079
Operating income: 5451591.673224122
Net income: 3034752.128192289
Capital expenditures: 6693347.163602547
Operating cash flow: 4900608.054939552
Depreciation & amortization: 3326504.0417769514
Net tangible assets: 38507339.58079977
Owner earnings: -332090.9936333066
Return on net tangible assets (%): -0.8624096009969258
Capex to operating income (%): 122.7778521358706
Buffett classification: The Gruesome
Stock price: 3.8724515344445245
P/E ratio: 18.217433507547828
Shares outstanding: 14276588
Book value: 38674991.0580156
P/B ratio: 1.4294869525451148
Market cap (USD): 55285395.10723229
Debt to equity: 0.9830211618612611
Current ratio: 1.0954111000560758
Quick ratio: 0.6860780082724074
Effective tax rate (%): 36.38152281005888
Interest coverage ratio: 36.54174058978662
COGS to revenue (%): 80.88622446487817
Free cash flow (dilution-adjusted): -1878703.7699406254
Buyback yield (%): 0
Retained earnings: 17685771.514414478
Inventory turnover: 11.173131509901987
Receivables turnover: 10.83294767289422
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.43485669848341
FCF margin (%): -0.4051244141234629
Revenue growth (%): 6.398420286188994
Rule of 40 score: 5.993295872065531
Financial ratios for 3160.T — annual report dated 2024-05-31
Total revenue: 449223300.41414464
Gross profit: 86284096.84612934
Operating income: 6907709.461611979
Net income: 4845205.479452055
Capital expenditures: 20802344.695762984
Operating cash flow: 10905065.307422746
Depreciation & amortization: 3281573.749601784
Net tangible assets: 38463924.816820644
Owner earnings: -12675565.466709144
Return on net tangible assets (%): -32.954425548289336
Capex to operating income (%): 301.1467811633838
Buffett classification: The Gruesome
Stock price: 3.702771583306786
P/E ratio: 10.910361712658869
Shares outstanding: 14276588
Book value: 38668639.69417013
P/B ratio: 1.3670753554061155
Market cap (USD): 52862944.35297866
Debt to equity: 1.2122215973754014
Current ratio: 1.0859892900251127
Quick ratio: 0.6773568088933258
Effective tax rate (%): 15.174273919091211
Interest coverage ratio: 38.98051270988387
COGS to revenue (%): 80.79260289080312
Free cash flow (dilution-adjusted): -10048805.352022938
Buyback yield (%): 0
Retained earnings: 19568225.549538072
Inventory turnover: 11.781264038042007
Receivables turnover: 11.29023118636338
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.067689788014787
FCF margin (%): -2.2369287930431967
Revenue growth (%): -3.1293121870722693
Rule of 40 score: -5.366240980115466
Financial ratios for 3160.T — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 42146080.57154197
Buffett classification: The Gruesome
Stock price: 3.7379109611695442
Shares outstanding: 14276588
Book value: 42389733.41271417
P/B ratio: 1.2589042316858652
Market cap (USD): 53364614.77330158
Debt to equity: 1.18585121603182
Current ratio: 1.0482869405821473
Quick ratio: 0.6812866216163963
Buyback yield (%): 0
Retained earnings: 22988112.720777933
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3160.T — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 43915203.78355821
Buffett classification: The Gruesome
Stock price: 3.8249408819029074
Shares outstanding: 14276588
Book value: 44349234.9422729
P/B ratio: 1.2312975672830366
Market cap (USD): 54607105.09528446
Debt to equity: 1.5839052350234843
Current ratio: 1.0402083488956522
Quick ratio: 0.6413834553076473
Buyback yield (%): 0
Retained earnings: 23672110.1683127
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3160.T — annual report dated 2025-05-31
Total revenue: 520799353.1784671
Gross profit: 99999833.0783141
Operating income: 5641493.949088885
Net income: 3639073.5846432047
Capital expenditures: 12904326.053693142
Operating cash flow: -1152900.2642926692
Depreciation & amortization: 4400806.788148561
Net tangible assets: 43915203.78355821
Owner earnings: -4864445.6809013765
Return on net tangible assets (%): -11.076905631308074
Capex to operating income (%): 228.73951776155357
Buffett classification: The Gruesome
Stock price: 3.8249408819029074
P/E ratio: 15.005771063746833
Shares outstanding: 14276588
Book value: 44349234.9422729
P/B ratio: 1.2312975672830366
Market cap (USD): 54607105.09528446
Debt to equity: 1.5839052350234843
Current ratio: 1.0402083488956522
Quick ratio: 0.6413834553076473
Effective tax rate (%): 25.694801450810758
Interest coverage ratio: 12.899918891839881
COGS to revenue (%): 80.79877932489555
Free cash flow (dilution-adjusted): -14336827.096953679
Buyback yield (%): 0
Retained earnings: 23672110.1683127
Inventory turnover: 10.39634074569717
Receivables turnover: 9.920276806615592
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.303743455312249
FCF margin (%): -2.752850403798552
Revenue growth (%): 15.93329034765908
Rule of 40 score: 13.180439943860527
Financial ratios for 3421.T — annual report dated 2021-07-31
Total revenue: 345485220.7293666
Gross profit: 98175815.73896353
Operating income: 25267672.059226763
Net income: 21618627.182158854
Capital expenditures: 27322877.250708345
Operating cash flow: 46039575.90713829
Depreciation & amortization: 15729485.42180788
Net tangible assets: 360227785.3943881
Owner earnings: 10025235.35325839
Return on net tangible assets (%): 2.783026673603888
Capex to operating income (%): 108.13373383453859
Buffett classification: The Gruesome
Stock price: 11.89534777442647
P/E ratio: 8.660503952371249
Shares outstanding: 15739616
Book value: 363222694.45206106
P/B ratio: 0.5154639537002775
Market cap (USD): 187228206.15592727
Debt to equity: 0
Current ratio: 2.0386254669961703
Quick ratio: 1.8214685035212779
Effective tax rate (%): 22.638537426012906
Interest coverage ratio: 8832.38338658147
COGS to revenue (%): 71.58320559367684
Free cash flow (dilution-adjusted): 15699259.665478475
Buyback yield (%): 7.367472138795295
Retained earnings: 358292816.01316154
Inventory turnover: 8.993412682057793
Receivables turnover: 5.63076730569705
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.487800488968912
FCF margin (%): 4.544119031296097
Rule of 40 score: 4.544119031296097
Financial ratios for 3421.T — annual report dated 2022-07-31
Total revenue: 291315520.8333333
Gross profit: 71600930.0595238
Operating income: 14069523.80952381
Net income: 11316629.464285715
Capital expenditures: 13660684.523809522
Operating cash flow: 22963288.69047619
Depreciation & amortization: 14577165.178571427
Net tangible assets: 300833125
Owner earnings: 12233110.11904762
Return on net tangible assets (%): 4.066410611879133
Capex to operating income (%): 97.09414980031137
Buffett classification: The Gruesome
Stock price: 9.013020833333332
P/E ratio: 12.535665974075497
Shares outstanding: 15739616
Book value: 303321666.6666666
P/B ratio: 0.46769321979416795
Market cap (USD): 141861486.91666666
Debt to equity: 0
Current ratio: 1.9444590399139352
Quick ratio: 1.728375066230616
Effective tax rate (%): 30.26410083708425
Interest coverage ratio: 3135.893864013267
COGS to revenue (%): 75.42151895830915
Free cash flow (dilution-adjusted): 8652269.345238095
Buyback yield (%): 0
Retained earnings: 299038735.1190476
Inventory turnover: 8.60561443755812
Receivables turnover: 4.850667869892979
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.350361280481527
FCF margin (%): 2.970068096779577
Revenue growth (%): -15.679310328144759
Rule of 40 score: -12.709242231365181
Financial ratios for 3421.T — annual report dated 2023-07-31
Total revenue: 297134718.6700767
Gross profit: 74665622.33589089
Operating income: 19566489.059391875
Net income: 14000753.054845128
Capital expenditures: 10623138.67576016
Operating cash flow: 21141311.45211708
Depreciation & amortization: 13157416.879795397
Net tangible assets: 299231450.6962205
Owner earnings: 16535031.258880368
Return on net tangible assets (%): 5.525833337507933
Capex to operating income (%): 54.292513304327706
Buffett classification: The Good
Stock price: 10.256322818982667
P/E ratio: 11.53013570844746
Shares outstanding: 15739616
Book value: 301475213.12872976
P/B ratio: 0.5354688402654646
Market cap (USD): 161430582.7428247
Debt to equity: 0
Current ratio: 2.2541679297304453
Quick ratio: 1.9668363612282644
Effective tax rate (%): 32.02814694021707
Interest coverage ratio: 4147.859939759036
COGS to revenue (%): 74.87145808134397
Free cash flow (dilution-adjusted): 9973621.7675476
Buyback yield (%): 0
Retained earnings: 296460862.4609264
Inventory turnover: 7.879111846036674
Receivables turnover: 5.91143967296523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.077814582871984
FCF margin (%): 3.3565992598198537
Revenue growth (%): 1.9975584617314912
Rule of 40 score: 5.354157721551345
Financial ratios for 3421.T — annual report dated 2024-07-31
Total revenue: 277815890.4827406
Gross profit: 73232789.67708129
Operating income: 20075646.819938432
Net income: 15992984.869326
Capital expenditures: 15004296.84941377
Operating cash flow: 24327549.616820596
Depreciation & amortization: 12071939.47730399
Net tangible assets: 283475443.76760334
Owner earnings: 13060627.49721622
Return on net tangible assets (%): 4.607322356967005
Capex to operating income (%): 74.73879663250513
Buffett classification: The Good
Stock price: 10.851706294622389
P/E ratio: 10.679788133216526
Shares outstanding: 15739616
Book value: 285386985.0003275
P/B ratio: 0.5984915185320846
Market cap (USD): 170801690.02213925
Debt to equity: 0
Current ratio: 2.22654198173735
Quick ratio: 1.9457993538527072
Effective tax rate (%): 29.728610409431422
Interest coverage ratio: 8044.485564304463
COGS to revenue (%): 73.639812485229
Free cash flow (dilution-adjusted): 8826593.305823017
Buyback yield (%): 2.875945483468824
Retained earnings: 279296161.65585905
Inventory turnover: 7.859011995461789
Receivables turnover: 6.122001671152953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.607405267580113
FCF margin (%): 3.1771376685781663
Revenue growth (%): -6.501706792731546
Rule of 40 score: -3.3245691241533795
Financial ratios for 3421.T — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.203981723237598
Shares outstanding: 15739616
Market cap (USD): 176346369.99477807
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3421.T — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 283344665.80142766
Buffett classification: The Gruesome
Stock price: 10.750162232316677
Shares outstanding: 15739616
Book value: 283344665.80142766
P/B ratio: 0.5971646757343498
Market cap (USD): 169203425.4743673
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3421.T — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.818669168397776
Shares outstanding: 15739616
Market cap (USD): 186021314.34162033
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3421.T — quarterly report dated 2025-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.152566601689408
Shares outstanding: 15739616
Market cap (USD): 159797499.72501624
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3512.T — annual report dated 2022-03-31
Total revenue: 80641288.31339125
Gross profit: 26649852.483199477
Operating income: 5158523.192919194
Net income: 4091009.670545812
Capital expenditures: 2218996.8857564335
Operating cash flow: 10499344.369775446
Depreciation & amortization: 4299524.668087199
Net tangible assets: 138749868.8739551
Owner earnings: 6171537.452876579
Return on net tangible assets (%): 4.447959124547357
Capex to operating income (%): 43.01612695669028
Buffett classification: The Good
Stock price: 3.6951319455826916
P/E ratio: 15.130267732884604
Shares outstanding: 16751248
Book value: 142553458.44943452
P/B ratio: 0.43420953996099776
Market cap (USD): 61898071.61317817
Debt to equity: 0.09316673846191524
Current ratio: 3.548408203601478
Quick ratio: 2.6920499160817113
Effective tax rate (%): 30.209909147628693
Interest coverage ratio: 64.80417996499536
COGS to revenue (%): 66.95258565933423
SG&A to revenue (%): 26.650528209271478
Free cash flow (dilution-adjusted): 8255785.936731684
Buyback yield (%): 1.7810342117283988
Retained earnings: 99740968.69365679
Inventory turnover: 2.1696865267048238
Receivables turnover: 2.5231898529296375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.27093008004553
FCF margin (%): 10.237666224586757
Rule of 40 score: 10.237666224586757
Financial ratios for 3512.T — annual report dated 2023-03-31
Total revenue: 78076321.32132132
Gross profit: 26311058.55855856
Operating income: 6190037.537537538
Net income: 5756756.756756757
Capital expenditures: 4220683.183183184
Operating cash flow: 7973370.8708708715
Depreciation & amortization: 4185315.3153153155
Net tangible assets: 133406073.57357359
Owner earnings: 5721388.88888889
Return on net tangible assets (%): 4.288701957586315
Capex to operating income (%): 68.18509835502897
Buffett classification: The Good
Stock price: 2.7849849849849853
P/E ratio: 8.10386405592071
Shares outstanding: 16751248
Book value: 136741051.05105105
P/B ratio: 0.34117021773031914
Market cap (USD): 46651974.15975977
Debt to equity: 0.08825305365548129
Current ratio: 3.665720327302311
Quick ratio: 2.7823114100848736
Effective tax rate (%): 27.375677892419915
Interest coverage ratio: 86.3635697077616
COGS to revenue (%): 66.30083792269942
SG&A to revenue (%): 25.770964462085015
Free cash flow (dilution-adjusted): 3746126.1261261264
Buyback yield (%): 0.0010299252906963258
Retained earnings: 95146231.23123124
Inventory turnover: 2.1865935680813555
Receivables turnover: 2.568156708497283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.118454782127437
FCF margin (%): 4.798031032621311
Revenue growth (%): -3.1807118235783354
Rule of 40 score: 1.6173192090429755
Financial ratios for 3512.T — annual report dated 2024-03-31
Total revenue: 66580097.72847332
Gross profit: 20955923.137876388
Operating income: 3096269.149498151
Net income: 3299451.9281563656
Capital expenditures: 3298890.649762282
Operating cash flow: 4037156.6296883253
Depreciation & amortization: 3672543.5816164818
Net tangible assets: 131504694.92868464
Owner earnings: 3673104.8600105653
Return on net tangible assets (%): 2.7931359119934847
Capex to operating income (%): 106.54405319695712
Buffett classification: The Gruesome
Stock price: 2.674986793449551
P/E ratio: 13.580851653394546
Shares outstanding: 16751248
Book value: 134485730.32223982
P/B ratio: 0.3331904958721714
Market cap (USD): 44809367.1737982
Debt to equity: 0.03935169284451605
Current ratio: 4.687477004954096
Quick ratio: 3.402537953007266
Effective tax rate (%): 24.709638728497897
Interest coverage ratio: 81.16652241647914
COGS to revenue (%): 68.52524425040836
SG&A to revenue (%): 26.824313267327128
Free cash flow (dilution-adjusted): 720437.1368198626
Buyback yield (%): 4.001779820863869
Retained earnings: 80702740.35921818
Inventory turnover: 2.091299435233454
Receivables turnover: 2.354384636813002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.084076695608238
FCF margin (%): 1.082060798045005
Revenue growth (%): -14.72434074542979
Rule of 40 score: -13.642279947384786
Financial ratios for 3512.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 137899859.92435914
Buffett classification: The Gruesome
Stock price: 3.2349768875192604
Shares outstanding: 16751248
Book value: 141365016.1086987
P/B ratio: 0.38333317258235533
Market cap (USD): 54189900.117103234
Debt to equity: 0.039653198258014714
Current ratio: 4.608798047224639
Quick ratio: 3.224108234686031
Buyback yield (%): 0
Retained earnings: 86239494.32693654
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3512.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 135173105.1998396
Buffett classification: The Gruesome
Stock price: 3.1168961368800963
Shares outstanding: 16751248
Book value: 138483765.5393664
P/B ratio: 0.3770254222635093
Market cap (USD): 52211900.17912044
Debt to equity: 0.038610148552063926
Current ratio: 4.315640771961899
Quick ratio: 2.9963511743934212
Buyback yield (%): 0
Retained earnings: 82118780.91164282
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3512.T — annual report dated 2025-03-31
Total revenue: 64827142.09330303
Gross profit: 19820632.268413313
Operating income: 1338631.199037562
Net income: 2895428.4186606067
Capital expenditures: 5785068.841064028
Operating cash flow: 7110707.124715947
Depreciation & amortization: 3628886.512498329
Net tangible assets: 135173105.1998396
Owner earnings: 739246.0900949072
Return on net tangible assets (%): 0.5468884427874965
Capex to operating income (%): 432.1630069001327
Buffett classification: The Gruesome
Stock price: 3.1168961368800963
P/E ratio: 18.03253012321855
Shares outstanding: 16751248
Book value: 138483765.5393664
P/B ratio: 0.3770254222635093
Market cap (USD): 52211900.17912044
Debt to equity: 0.038610148552063926
Current ratio: 4.315640771961899
Quick ratio: 2.9963511743934212
Effective tax rate (%): 23.972292615810126
Interest coverage ratio: 29.35453612780302
COGS to revenue (%): 69.42541098003936
SG&A to revenue (%): 28.509665045507276
Free cash flow (dilution-adjusted): 1252466.2478278305
Buyback yield (%): 3.1897179997488916
Retained earnings: 82118780.91164282
Inventory turnover: 1.9687329881505433
Receivables turnover: 2.662198214082803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.883392896318945
FCF margin (%): 1.9320090434114887
Revenue growth (%): -2.632852301177425
Rule of 40 score: -0.7008432577659363
Financial ratios for 3512.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 142354380.88829073
Buffett classification: The Gruesome
Stock price: 3.9372139973082105
Shares outstanding: 16751248
Book value: 145620026.9179004
P/B ratio: 0.4529133079694125
Market cap (USD): 65953248.09798117
Debt to equity: 0.036970052778447345
Current ratio: 4.369175016123936
Quick ratio: 3.0070889551330287
Buyback yield (%): 0
Retained earnings: 83453829.07133244
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3737.HK — annual report dated 2021-12-31
Total revenue: 274175824.17582417
Gross profit: 166630926.2166405
Operating income: 16048351.648351649
Net income: 8220722.135007849
Capital expenditures: 25255729.98430141
Operating cash flow: 28002982.731554158
Depreciation & amortization: 13351962.323390896
Net tangible assets: 133447409.73312402
Owner earnings: -3683045.525902666
Return on net tangible assets (%): -2.759922828976776
Capex to operating income (%): 157.372735454083
Buffett classification: The Gruesome
Stock price: 0.10256410256410257
P/E ratio: 10.5267999592611
Shares outstanding: 843744500
Book value: 141470172.6844584
P/B ratio: 0.6117041903166087
Market cap (USD): 86537897.43589744
Debt to equity: 0.19501534125271175
Current ratio: 1.7120286084527514
Quick ratio: 1.1768041515002066
Effective tax rate (%): 15.283192855871745
Interest coverage ratio: 14.43898305084746
COGS to revenue (%): 39.22479244202691
R&D to revenue (%): 2.509819639278557
SG&A to revenue (%): 53.37165760091611
Free cash flow (dilution-adjusted): -1488854.0031397175
Buyback yield (%): 0
Inventory turnover: 2.555654207873699
Receivables turnover: 7.105312405920213
Capitalized R&D asset: 6881318.681318681
ROCI (R&D-adjusted, %): 12.318403260650907
FCF margin (%): -0.5430289149728028
Rule of 40 score: -0.5430289149728028
Financial ratios for 3737.HK — annual report dated 2022-12-31
Total revenue: 262346982.75862068
Gross profit: 154065373.56321838
Operating income: 18557327.586206898
Net income: 15361350.574712643
Capital expenditures: 9169683.908045977
Operating cash flow: 40887068.965517245
Depreciation & amortization: 13848275.862068966
Net tangible assets: 141659482.75862068
Owner earnings: 20039942.52873563
Return on net tangible assets (%): 14.14655915614382
Capex to operating income (%): 49.41273933678644
Buffett classification: The Good
Stock price: 0.11296534017971759
P/E ratio: 6.204785445374077
Shares outstanding: 843744500
Book value: 144532902.2988506
P/B ratio: 0.6594614994320481
Market cap (USD): 95313884.46726573
Debt to equity: 0.2101627418487418
Current ratio: 1.4918543701136817
Quick ratio: 1.0502809568807425
Effective tax rate (%): 18.167484366748056
Interest coverage ratio: 19.703890160183068
COGS to revenue (%): 41.27419650754271
R&D to revenue (%): 2.5384255189806866
SG&A to revenue (%): 50.08759895615123
Free cash flow (dilution-adjusted): 28078448.275862068
Buyback yield (%): 0
Retained earnings: 95040948.27586207
Inventory turnover: 2.3339661382281256
Receivables turnover: 9.265648390125085
Capitalized R&D asset: 11269966.275104206
ROCI (R&D-adjusted, %): 11.787388778435332
Rosenberg metric: -1.8260384724711158
FCF margin (%): 10.702790625077014
Revenue growth (%): -4.314326929721512
Rule of 40 score: 6.388463695355503
Financial ratios for 3737.HK — annual report dated 2023-12-31
Total revenue: 288299859.3530239
Gross profit: 171328129.39521798
Operating income: 27972292.545710266
Net income: 23084950.773558367
Capital expenditures: 17933895.921237692
Operating cash flow: 14276090.014064698
Depreciation & amortization: 14357102.672292545
Net tangible assets: 145241912.79887483
Owner earnings: 19508157.524613217
Return on net tangible assets (%): 13.431493119776885
Capex to operating income (%): 64.11307150435181
Buffett classification: The Good
Stock price: 0.16645326504481436
P/E ratio: 6.083791482434944
Shares outstanding: 843744500
Book value: 148148101.26582277
P/B ratio: 0.9479974814972827
Market cap (USD): 140444026.88860437
Debt to equity: 0.2136655739448019
Current ratio: 1.4362627504074872
Quick ratio: 0.8940138808559861
Effective tax rate (%): 20.930142932156603
Interest coverage ratio: 25.277452974072194
COGS to revenue (%): 40.57294034770018
R&D to revenue (%): 2.4383699578302793
SG&A to revenue (%): 48.531621436502476
Free cash flow (dilution-adjusted): -9834880.450070323
Buyback yield (%): 0
Retained earnings: 114843600.5625879
Inventory turnover: 2.5200792686437365
Receivables turnover: 10.674269526591782
Capitalized R&D asset: 13762505.772042109
ROCI (R&D-adjusted, %): 15.61089034785297
Rosenberg metric: 2.5922067009863476
FCF margin (%): -3.4113372348293405
Revenue growth (%): 9.892576739974114
Rule of 40 score: 6.4812395051447735
Financial ratios for 3737.HK — annual report dated 2024-12-31
Total revenue: 303394931.50684935
Gross profit: 176494109.5890411
Operating income: 21346712.328767125
Net income: 13170821.91780822
Capital expenditures: 17451917.80821918
Operating cash flow: 24860273.97260274
Depreciation & amortization: 15263150.684931507
Net tangible assets: 151102602.73972604
Owner earnings: 10982054.79452055
Return on net tangible assets (%): 7.267945485649323
Capex to operating income (%): 81.75459311690229
Buffett classification: The Gruesome
Stock price: 0.1211340206185567
P/E ratio: 7.760044460217113
Shares outstanding: 843744500
Book value: 153635890.41095892
P/B ratio: 0.6652492681651644
Market cap (USD): 102206163.65979381
Debt to equity: 0.26854366577444266
Current ratio: 1.3862355173299945
Quick ratio: 0.9141619871945587
Effective tax rate (%): 34.548016637507914
Interest coverage ratio: 22.280669144981413
COGS to revenue (%): 41.82694196225996
R&D to revenue (%): 2.5741122267960335
SG&A to revenue (%): 49.41712122587178
Free cash flow (dilution-adjusted): 5427671.232876712
Buyback yield (%): 0
Retained earnings: 122820821.91780822
Inventory turnover: 2.68241098936737
Receivables turnover: 6.992498508226069
Capitalized R&D asset: 14717332.834225914
ROCI (R&D-adjusted, %): 11.777575040633918
Rosenberg metric: 0.7348669356584859
FCF margin (%): 1.7889788751313331
Revenue growth (%): 5.235892999636017
Rule of 40 score: 7.02487187476735
Financial ratios for 3737.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 151102602.73972604
Buffett classification: The Gruesome
Stock price: 0.1211340206185567
Shares outstanding: 843744500
Book value: 153635890.41095892
P/B ratio: 0.6652492681651644
Market cap (USD): 102206163.65979381
Debt to equity: 0.26854366577444266
Current ratio: 1.3862355173299945
Quick ratio: 0.9141619871945587
Buyback yield (%): 0
Retained earnings: 122820821.91780822
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3737.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 148452440.72524408
Buffett classification: The Gruesome
Stock price: 0.11210191082802548
Shares outstanding: 843744500
Book value: 152141004.18410045
P/B ratio: 0.621695454212873
Market cap (USD): 94585370.70063694
Debt to equity: 0.2579527359831911
Current ratio: 1.5392599829038955
Quick ratio: 1.0601202436591375
Buyback yield (%): 0
Retained earnings: 124976708.50767085
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3QD.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 180.22727272727272
Shares outstanding: 330825798
Market cap (USD): 59623831321.36363
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3QD.DE — annual report dated 2022-12-31
Total revenue: 1675100000
Gross profit: 1328357000
Operating income: -58695000
Net income: -50160000
Capital expenditures: 35261000
Operating cash flow: 418407000
Depreciation & amortization: 34629000
Net tangible assets: 1045863000
Owner earnings: -50792000
Return on net tangible assets (%): -4.856467816530463
Buffett classification: The Gruesome
Stock price: 72.79787234042554
Shares outstanding: 330825798
Book value: 1410505000
P/B ratio: 17.074320338973212
Market cap (USD): 24083414209.723408
Debt to equity: 0.5937738611348418
Current ratio: 3.0855415216624458
Quick ratio: 3.0855415216624458
Interest coverage ratio: -3.549742969458724
COGS to revenue (%): 20.6998388155931
R&D to revenue (%): 44.91379619127216
SG&A to revenue (%): 37.89033490537878
Free cash flow (dilution-adjusted): -9636000
Buyback yield (%): 0
Retained earnings: -202266000
Receivables turnover: 4.192456031895803
Capitalized R&D asset: 752351000
ROCI (R&D-adjusted, %): 14.774945189613634
FCF margin (%): -0.5752492388514119
Rule of 40 score: -0.5752492388514119
Financial ratios for 3QD.DE — annual report dated 2023-12-31
Total revenue: 2128359000
Gross profit: 1718451000
Operating income: -33464000
Net income: 48568000
Capital expenditures: 27586000
Operating cash flow: 659954000
Depreciation & amortization: 44465000
Net tangible assets: 1663043000
Owner earnings: 65447000
Return on net tangible assets (%): 3.935376295140895
Buffett classification: The Gruesome
Stock price: 123.75555555555555
P/E ratio: 842.9733656646351
Shares outstanding: 330825798
Book value: 2025354000
P/B ratio: 20.214505920249003
Market cap (USD): 40941530423.6
Debt to equity: 0.44552063491123034
Current ratio: 3.168466839206741
Quick ratio: 3.168466839206741
Effective tax rate (%): 19.36913754461692
Interest coverage ratio: -5.310060298317994
COGS to revenue (%): 19.259344875559055
R&D to revenue (%): 45.2201437821345
SG&A to revenue (%): 37.09280248303975
Free cash flow (dilution-adjusted): 115248000
Buyback yield (%): 0
Retained earnings: -153698000
Receivables turnover: 4.179161127790465
Capitalized R&D asset: 1466522170
ROCI (R&D-adjusted, %): 8.123201298162956
Rosenberg metric: 0.5185000086395845
FCF margin (%): 5.4148759678230975
Revenue growth (%): 27.058623365769208
Rule of 40 score: 32.47349933359231
Financial ratios for 3QD.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 208000
Buffett classification: The Gruesome
Stock price: 114.2
Shares outstanding: 330825798
Market cap (USD): 37780306131.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3QD.DE — annual report dated 2024-12-31
Total revenue: 2684275000
Gross profit: 2168744000
Operating income: 54284000
Net income: 183746000
Capital expenditures: 34719000
Operating cash flow: 870603000
Depreciation & amortization: 54933000
Net tangible assets: 2350271000
Owner earnings: 203960000
Return on net tangible assets (%): 8.67814817950781
Capex to operating income (%): 63.9580723601798
Buffett classification: The Good
Stock price: 144.04166666666669
P/E ratio: 259.3400635673702
Shares outstanding: 330825798
Book value: 2714363000
P/B ratio: 17.555757767199893
Market cap (USD): 47652699320.25001
Debt to equity: 0.6786785702575522
Current ratio: 2.6365387475150492
Quick ratio: 2.6365387475150492
Effective tax rate (%): 9.901931940766891
Interest coverage ratio: 7.680249009620827
COGS to revenue (%): 19.20559555187155
R&D to revenue (%): 42.94280578554731
SG&A to revenue (%): 35.82930213931136
Free cash flow (dilution-adjusted): 204767000
Buyback yield (%): 0
Retained earnings: 30048000
Receivables turnover: 4.481866496137207
Capitalized R&D asset: 2045818320
ROCI (R&D-adjusted, %): 4.208020044548784
Rosenberg metric: 0.4678626459431013
FCF margin (%): 7.628391278836929
Revenue growth (%): 26.119465748024652
Rule of 40 score: 33.74785702686158
Financial ratios for 3QD.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 144.04166666666669
Shares outstanding: 330825798
Market cap (USD): 47652699320.25001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0